Neuralink taps brain implants to control robotic arms

Neuralink already proved paralyzed patients could browse the web and play video games with their thoughts. Now, it wants to give them a physical hand.

Neuralink announced regulatory approval and the launch of the CONVOY Study, a new feasibility trial aimed at using its N1 brain implant to control an investigational assistive robotic arm.

The company stated that participants from its ongoing PRIME Study will be able to cross-enroll into this new trial.

Moving from pixels to physical objects

Until now, Neuralink's public demonstrations have focused almost entirely on digital interfaces, like moving a mouse cursor or typing messages.

Controlling a physical robotic arm takes that capability into the real world. Neuralink called the new trial an essential first step toward restoring not just digital freedom, but physical freedom for people with severe paralysis.

Why it matters

Clicking a link on an iPad improves life, but being able to pick up a cup of water or reach for an object independently completely transforms daily living for a paralyzed patient.

Cross-enrolling patients who already have the N1 implant from the PRIME trial looks like a very smart operational shortcut. It skips the arduous process of recruiting new candidates and putting them through invasive neurosurgery, allowing researchers to jump straight into decoding motor commands on existing hardware.

That said, manipulating a physical robotic arm in three-dimensional space is infinitely more complex than nudging a 2D cursor. Ensuring real-time precision and absolute physical safety around vulnerable patients will be the real hurdle this trial has to clear.